Multitargeted comparative evaluation suggests 2-Aoeobenoxmide shows favourable in silico binding compared to Tucatinib against ERα, HER2, AKT1, EGFR, and PIK3CA in breast cancer

M Mohammed H. Al-Qahtani M Mohammad Alam Jafri M Mourad Assidi A Abdelbaset Buhmeida P Peter Natesan Pushparaj M Maha Khalid Abdullah N Nofe Ateq Alganmi

Article Details

Volume / Issue Vol. 1, Issue 1
Published June 18, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (7)

M

Mohammed H. Al-Qahtani

M

Mohammad Alam Jafri

M

Mourad Assidi

A

Abdelbaset Buhmeida

P

Peter Natesan Pushparaj

M

Maha Khalid Abdullah

N

Nofe Ateq Alganmi